Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2027-11-16 (359 days left) |
| Published | 2024-12-02 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-25-266. CFDA: 93.865
The buyer, the value, the full description and the link to the official notice are available with a free account.